Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19
Pierre‐François Dequin(Université de Tours), Stéphan Ehrmann(Inserm), Hélène Bourgoin(Centre Hospitalier Universitaire de Tours), Amélie Le Gouge(Centre Hospitalier Universitaire de Tours), Antoine Guillon(Université de Tours), Carine Coffre(Centre Hospitalier Universitaire de Tours), Nicholas Heming(Université de Versailles Saint-Quentin-en-Yvelines), Jean-Damien Ricard(Inserm), Gaëtan Plantefève(Centre Hospitalier Victor Dupouy), Julio Badié(Assistance Publique – Hôpitaux de Paris), Cécile Aubron(Université de Bretagne Occidentale), Caroline Caille-Fénérol(Inserm), Djillali Annane(Hôpital Raymond-Poincaré), Youenn Jouan(Université de Tours), Guillaume Voiriot(Délégation Paris 7), Sarah Zohar(Inserm), Céline Lengellé(Centre Hospitalier Universitaire de Tours), Bruno Giraudeau(Inserm), Bruno François(Inserm), Ferhat Meziani(Université de Strasbourg), Elsa Tavernier(Inserm), M Leclerc(Nottingham University Hospitals NHS Trust)
Cited by 518
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Critical Care Medicine|2017|3.8k